A monthly publication planned.

The study by Swiss and British scientists new ground in a rapidly evolving field be classified be classified after all individuals on the basis of their metabolic type or metabotype what a healthier diet used to create a healthier diet to individual needs to individual needs. Design The study is published in for second November issue of of the American Chemical Society Journal of Proteome Research, a monthly publication planned. Sunil Kochhar and colleagues studied 11 volunteers, who call themselves ‘chocolate craving ‘and 11 volunteers who were classified as’chocolate indifferent. ‘In a controlled clinical study, each topic – ate chocolate or placebo over a period of five days, while their blood and urine samples were analyzed – all men.

However, the researchers are planning to women in future clinical trials on metabolic responses to chocolate are to determine whether. Gender-specific response to treatment.. The study showed that MRI scans in women with newly diagnosed breast cancer by 13 per cent in 2004 to 27 % in 2006. Above all, the researchers observed that patients who received an MRI were significantly more likely to undergo mastectomy as the initial surgery compared to BCT. In addition, women experience, the MRI received an average delay of 22.4 days – from the first symptoms or abnormal imaging study – jn the treatment evaluation (p= 0, there was no statistically significant difference between groups in either the ability to completely remove the malignant cells achieve with a single excision or the number of unwanted by mastectomy BCT.

Women were not included in the current study to assess any metabolic changes associated with the menstrual cycle shown shown in studies by others that to avoid influencing metabolic differences, Kochhar says.Inflammation, as caused, for example, as described by the events Cramer and colleagues know well as promote a high cellular MUC1. Her research suggests that which increase in blood levels from MUC1 due to injury or surgery may cause said immune system, antibodies and might immune cells against MUC1 which then generate effectively be trapped highly early ovarian cancer tumor in the bud.

Addition to the presenting a new model to account for risk factors of ovarian cancer, speculates Cramer and Finn, the results of these research development of preventive development of preventive vaccine of ovarian cancer and perhaps others types of cancer that MUC1. Currently MUC1 vaccines cancer patients in cancer patients in order to treat the cancer or prevent its return. – ‘Treatment of may be be more successful earlier in the course of illness or prevent the disease is first and foremost to in women at high risk of ovarian cancer,’said Finn.